Collegium Pharmaceutical
COLL
COLL
244 hedge funds and large institutions have $1.3B invested in Collegium Pharmaceutical in 2025 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 84 increasing their positions, 87 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.4% more ownership
Funds ownership: 111.08% → 117.48% (+6.4%)
3% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 87
Holders
244
Holding in Top 10
–
Calls
$478K
Puts
$38K
Top Buyers
| 1 | +$19.7M | |
| 2 | +$15.3M | |
| 3 | +$8.42M | |
| 4 |
Walleye Capital
New York
|
+$7.97M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$7.84M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$10.5M | |
| 3 | -$9.35M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.71M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$7.2M |
